Serum β-hCG as an Indicator for Persistence in Gestational Trophoblastic Neoplasia

Authors

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-06-18
DOI
https://doi.org/10.5281/zenodo.20741327
Primary Topic
Gestational Trophoblastic Disease Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Serum β-hCG as an Indicator for Persistence in Gestational Trophoblastic Neoplasia

Sayada Fatema Khatun, Dilruba Ferdous, Rogina Amin
Zenodo (CERN European Organization for Nuclear Research)
Gestational Trophoblastic Disease Studies
article

Serum β-hCG as an Indicator for Persistence in Gestational Trophoblastic Neoplasia

Sayada Fatema Khatun, Dilruba Ferdous, Rogina Amin
article en

Abstract

No abstract available for this paper.
Zenodo (CERN European Organization for Nuclear Research)
Bangladesh University (BD), National Institute of Cancer Research and Hospital (BD), Dhaka Medical College and Hospital (BD)
Zero hunger
Openalex Percentile: Top 5%
Gestational Trophoblastic Disease Studies
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Serum β-hCG as an Indicator for Persistence in Gestational Trophoblastic Neoplasia — Sayada Fatema Khatun, Dilruba Ferdous, et al. · Zenodo (CERN European Organization for Nuclear Research) (2026) | TGRS Research Map | TGRS